Internal Medicine, Hematology & Oncology · Mobile, AL
NPI
1346658416
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5 Mobile Infirmary Cir # G805
Mobile, AL, 36607
Phone (251) 435-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$202K
2,067 services
Medicare patients, 2024
719
Average age 73
Drug cost, 2024
$5.3M
2,066 prescriptions
Company payments, 2025
$1,426
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Usman Khan was code 99215 (office e&m - established), 689 times for 296 patients. In total Usman Khan billed 2,067 services in 15 codes, and Medicare paid $202K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 689 | 296 | $117.91 | $81K |
| 99214 Office E&M - Established | Office | 476 | 351 | $78.36 | $37K |
| 99233 Hospital E&M - Subsequent | Facility | 423 | 129 | $92.73 | $39K |
| 99232 Hospital E&M - Subsequent | Facility | 172 | 86 | $62.44 | $11K |
| 99223 Hospital E&M - Initial | Facility | 91 | 79 | $135.47 | $12K |
| 99213 Office E&M - Established | Office | 76 | 75 | $52.93 | $4,023 |
| 99205 Office E&M - New | Office | 73 | 73 | $152.95 | $11K |
| 99204 Office E&M - New | Office | 21 | 21 | $101.47 | $2,131 |
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $103.45 | $1,345 |
By year: 2022 $143K for 1,531 services; 2023 $183K for 1,825 services; 2024 $202K for 2,067 services.
Medicare prescription drug claims, 2024
In 2024, the drug Usman Khan prescribed most often to Medicare patients was Tamoxifen Citrate, with 186 prescriptions and refills. In total Usman Khan wrote 2,066 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamoxifen Citrate Generic | 186 | 290 | 39 | $2,680 |
| Ondansetron Hcl Generic | 167 | 167 | 74 | $973 |
| Anastrozole Generic | 138 | 228 | 27 | $1,797 |
| Letrozole Generic | 125 | 221 | 31 | $2,020 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 102 | 102 | 38 | $2,513 |
| Hydroxyurea Generic | 70 | 82 | 12 | $1,936 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 68 | 68 | 25 | $1,234 |
| Gabapentin Generic | 66 | 68 | 24 | $493 |
| Potassium Chloride Generic | 57 | 58 | 25 | $613 |
| Verzenio Abemaciclib | 52 | 52 | Under 11 | $812K |
| Prednisone Generic | 51 | 57 | 16 | $248 |
| Ondansetron Odt Ondansetron | 47 | 47 | 30 | $535 |
| Acyclovir Generic | 40 | 48 | 12 | $479 |
| Revlimid Lenalidomide | 40 | 40 | Under 11 | $652K |
| Imbruvica Ibrutinib | 35 | 35 | Under 11 | $472K |
Brand drugs: 401 claims; generic drugs: 1,665 claims; opioid claims: 248.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Usman Khan $1,426 ($1,426 in general payments such as food, travel and fees) from 34 companies. The largest payer was Pfizer Inc. with $130.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 7 | $130 |
| Celgene Corporation BMY | 4 | $106 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $89.23 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $78.27 |
| Gilead Sciences, Inc. GILD | 3 | $75.71 |
| Stemline Therapeutics Inc. | 3 | $70.84 |
| GlaxoSmithKline, LLC. GSK | 4 | $70.53 |
| Boston Scientific Corporation BSX | 2 | $67.28 |
| Janssen Biotech, Inc. JNJ | 4 | $63.41 |
| Daiichi Sankyo Inc. 4568.T | 2 | $52.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.